Related Experiment Video
Updated: Jan 16, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
PAK4 phosphorylates cyclin-dependent kinase 2 to promote the G1/S transition during adipogenesis
Hwang Chan Yu1, Su Hyeon Park1, Hye Jin Jo2
1Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
Abstract:
p21-activated kinase 4 (PAK4), a member of the PAK family (PAK1-6), was initially recognized for its role in tumor development. Recently, we discovered PAK4's involvement in triacylglycerol lipolysis in adipocytes. However, its function in adipogenesis remains unclear. Here we show that PAK4 plays a critical role in adipocyte differentiation. Following adipogenic stimulation, PAK4 protein levels increased. Knockdown of PAK4 in 3T3-L1 preadipocytes or human stromal vascular cells, as well as pharmacological inhibition of PAK4 in 3T3-L1 cells, impaired adipogenesis, as indicated by reduced expression of adipocyte marker genes and decreased lipid accumulation. Mechanistically, PAK4 phosphorylated cyclin-dependent kinase 2 at serine 106, a critical step for CCAAT/enhancer-binding protein β expression during mitotic clonal expansion. Consistent with these findings, preadipocyte-specific Pak4-knockout mice exhibited reduced fat mass and smaller adipocytes. These results reveal PAK4 as a crucial regulator of adipogenesis and, together with its inhibitory role in triacylglycerol lipolysis, further underscore its potential as a therapeutic target for obesity treatment.
Insights
p21-activated kinase 4 (PAK4) is crucial for adipocyte differentiation, impacting fat mass. This discovery highlights PAK4 as a potential therapeutic target for obesity treatment.
Area of Science:
- Cell Biology
- Metabolism
- Molecular Biology
Background:
- p21-activated kinase 4 (PAK4) is known for its role in tumor development.
- Recent studies identified PAK4's involvement in triacylglycerol lipolysis in adipocytes.
- PAK4's function in adipogenesis was previously unclear.
Purpose of the Study:
- To investigate the role of PAK4 in adipocyte differentiation.
- To elucidate the molecular mechanisms by which PAK4 regulates adipogenesis.
- To assess the therapeutic potential of targeting PAK4 for obesity treatment.
Main Methods:
- Studied PAK4 protein levels during adipogenic stimulation.
- Utilized PAK4 knockdown in 3T3-L1 preadipocytes and human stromal vascular cells.
- Employed pharmacological inhibition of PAK4 in 3T3-L1 cells.
- Analyzed adipocyte marker gene expression and lipid accumulation.
- Investigated PAK4's phosphorylation of cyclin-dependent kinase 2 (CDK2).
- Examined fat mass and adipocyte size in preadipocyte-specific Pak4-knockout mice.
Main Results:
- PAK4 protein levels increased following adipogenic stimulation.
- PAK4 knockdown or inhibition impaired adipogenesis, reducing adipocyte marker gene expression and lipid accumulation.
- PAK4 was found to phosphorylate CDK2 at serine 106, a key step for CCAAT/enhancer-binding protein β expression during mitotic clonal expansion.
- Preadipocyte-specific Pak4-knockout mice showed reduced fat mass and smaller adipocytes.
Conclusions:
- PAK4 plays a critical role in regulating adipocyte differentiation.
- PAK4's function in promoting adipogenesis, alongside its inhibitory role in lipolysis, makes it a significant target for obesity therapeutics.
Related Concept Videos
Positive Regulator Molecules
Positive Regulator Molecules
cAMP-dependent Protein Kinase Pathways
PI3K/mTOR/AKT Signaling Pathway
Inhibition of Cdk Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...

